Tango Therapeutics, Inc. Share Price
NASDAQ: TNGXHealthcare
Live Tango Therapeutics, Inc. Share Price Chart
O H L
Tango Therapeutics, Inc. Performance Overview
Days Range
▼
$23.02Low
$23.36High
Markets Today
| Previous Close | $23.49 |
|---|---|
| Open | $23.36 |
| Volume | 187,368 |
| Day's Range | $23.02 - $23.36 |
| 52W Range | $6.69 - $34.39 |
| Market Cap | $3.94 B |
Historical Performance
| 1M Returns | -7.67 |
|---|---|
| 3M Returns | -16.02 |
| 6M Returns | +25.75 |
| 1Y Returns | +198.48 |
| 5Y Returns | +35.78 |
| 10Y Returns | NA |
Tango Therapeutics, Inc. Fundamentals
| Market Cap | $3.94 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $62.38 M |
| ROE TTM | -0.37 |
| EPS TTM | $-0.84 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.84 |
| EBITDA | $-109.01 M |
| Profit Margin | -162.85 |
| Market Cap | $3.94 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $62.38 M |
| ROE TTM | -0.37 |
| EPS TTM | $-0.84 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.84 |
| EBITDA | $-109.01 M |
| Profit Margin | -162.85 |
Tango Therapeutics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $5.39 M | $3.18 M | $53.81 M | $0 | $0 | $0 |
| Gross Profit + | $5.39 M | $3.18 M | $53.81 M | $0 | $0 | $0 |
| Operating Income | -$42.53 M | -$40.97 M | $14.07 M | -$41.86 M | -$48.77 M | -$59.78 M |
| EBITDA | -$41.91 M | -$40.34 M | $14.63 M | -$41.38 M | -$48.31 M | -$59.36 M |
| Interest Expense | $0 | $0 | $1.10 M | $1.68 M | $0 | $0 |
| Depreciation | $622.00 K | $625.00 K | $555.00 K | $479.00 K | $463.00 K | $425.00 K |
| Income Before Tax | -$39.84 M | -$38.82 M | $15.87 M | -$38.80 M | -$45.51 M | -$55.34 M |
| Income Tax Expense | $34.00 K | $35.00 K | -$10.00 K | -$55.00 K | $1.00 K | $1.00 K |
| Net Income + | -$39.88 M | -$38.85 M | $15.88 M | -$38.75 M | -$45.51 M | -$55.34 M |
| Net Profit Margin | -739.54% | -1221.41% | 29.52% | - | - | - |
Tango Therapeutics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $108.00 K | $111.00 K | $112.00 K | $136.00 K | $144.00 K | $168.00 K |
| Reserve & Surplus | -$541.24 M | -$580.19 M | -$564.28 M | -$602.93 M | -$648.78 M | -$704.64 M |
| Non-Current Liabilities | $71.63 M | $62.91 M | $31.66 M | $30.83 M | $29.96 M | $29.05 M |
| Current Liabilities | $35.92 M | $40.02 M | $18.44 M | $21.68 M | $14.33 M | $20.30 M |
| Total Liabilities | $107.55 M | $102.94 M | $50.10 M | $52.51 M | $44.29 M | $49.35 M |
| Fixed Assets | $7.54 M | $7.79 M | $7.35 M | $6.87 M | $6.38 M | $6.09 M |
| Current Assets | $224.93 M | $190.10 M | $163.78 M | $353.76 M | $392.33 M | $1.03 B |
| Total Assets | $274.31 M | $237.89 M | $210.14 M | $398.69 M | $435.79 M | $1.07 B |
Tango Therapeutics, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$39.88 M | -$38.85 M | $15.88 M | -$38.75 M | -$45.51 M | -$55.34 M |
| Operating Cash Flow | -$41.70 M | -$36.52 M | -$30.95 M | -$29.72 M | -$44.36 M | -$38.87 M |
| Investing Cash Flow | $30.60 M | $16.78 M | $47.48 M | -$135.72 M | $9.63 M | -$445.97 M |
| Financing Cash Flow | $2.00 K | $581.00 K | $2.54 M | $219.38 M | $79.85 M | $672.57 M |
| Change in Cash | -$11.10 M | -$19.16 M | $19.07 M | $53.94 M | $45.12 M | $187.73 M |
Tango Therapeutics, Inc. Return Calculator
The Tango Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$13,254
Invested Amount$10,000
Est. Returns$3,254
About Tango Therapeutics, Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Popular Stocks
FAQs
What is the share price of Tango Therapeutics, Inc. today?
Tango Therapeutics, Inc. (TNGX) share price as of September 18, 2026 is $22.93. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Tango Therapeutics, Inc.?
Yes, Indian Investors can invest in the Tango Therapeutics, Inc. (TNGX) Share by opening an international trading account with Angel One.
How can I purchase Tango Therapeutics, Inc. shares in India?
Purchasing Tango Therapeutics, Inc. (TNGX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Tango Therapeutics, Inc. (TNGX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Tango Therapeutics, Inc.?
Yes, you can purchase fractional shares of Tango Therapeutics, Inc. (TNGX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Tango Therapeutics, Inc.?
The market capitalization of Tango Therapeutics, Inc. on September 18, 2026, is $3.94 B.
In which sector Tango Therapeutics, Inc. belongs?
Tango Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Tango Therapeutics, Inc. stocks?
In order to invest in Tango Therapeutics, Inc. (TNGX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
